Table 3.
Antibiofilm drugs | Target pathogenic bacteria | Antibiofilm mechanism of action | Research Model | Reference |
---|---|---|---|---|
Exopolysaccharide-targeting drugs | ||||
Quinoxaline derivative | Streptococcus mutans | Glucosyltransferase inhibitor | Anticaries rat | [167] |
Oxazole derivative | S. mutans | Antagonizing glucosyltransferases | Dental caries rat | [168] |
Dispersin B | Staphylococcus spp. | Inhibiting skin colonization by inducing staphylococci to detach from the skin | In vivo pig model | [169] |
Endolysins | S. aureus | Peptidoglycan hydrolases | System MRSA infection in mice | [170] |
Dornase alfa | Pseudomonas aeruginosa | Dissolution of cystic fibrosis sputum and fibrous structures | Cystic fibrosis sputum | [171] |
DNABII antibodies | Haemophilus influenzae | DNABII epitope targeted to external cellular DNA | Chinchilla and murine | [172] |
α-amylase |
S. aureus and P. aeruginosa |
Destruction of exopolysaccharides | Danio rerio | [173] |
Biofilm dispersion-targeting drugs | ||||
Nitric oxide | P. aeruginosa | Biofilm dispersal and reduction of biofilm antibiotic tolerance | Cystic fibrosis sputum | [174] |
Cephalosporin-3′-diazeniumdiolates | P. aeruginosa | Biofilm dispersion; enhance biofilm sensitivity to antibiotics | Microtiter plates | [175] |
Nitroxides | P. aeruginosa | Promotes biofilm dispersion, inhibits biofilm formation, increases swarming motility | Flow chambers | [176] |
Autoinducing peptide inhibitor | S. aureus | Quorum sensing inhibitor | RN9222 cell line | [177] |
Natural peptide Capsicumicine | S. epidermidis | Decomposing biofilm substrates | SKH1 mice | [178] |
Biofilm persister-targeting drugs | ||||
TM5 peptide | P. aeruginosa and S. aureus | Anti-inflammatory antiseptic | Laboratory settings | [179] |
Rifampin + Fosfomycin | S.aureus (Methicillin-resistant) | Curing cage related infections | A foreign body infection model using guinea pigs | [180] |
Acyldepsipeptide ADEP4 | S. aureus | Activates ClpP protease to kill growing and stubborn cells | Mouse model of a chronic infection | [181] |
Glycosylated cationic peptides | S.aureus (Methicillin-resistant) | Sterilization of recalcitrant cells and dispersion of biofilm masses | Ex vivo wounded human skin infection | [164] |